WTO notification · TBT
PhilippinesUpdated: check whether it is now adopted or in force
Official title
Classification of Pharmaceutical Products Intended for Human Use
The Philippines issued an addendum on 27 November 2025 to the earlier TBT notification G/TBT/N/PHL/349. Addenda often report that a measure was adopted, changed, postponed or withdrawn. The measure was first notified on 17 November 2025. The comment period closed on 16 January 2026.
Expodite puts notifications like this one in your Updates centre, matched to the HS codes of your products and the markets you export to. Opens the requirements check for the Philippines in your Expodite account.
Source: WTO ePing (opens in a new tab). Summaries by Expodite, which is independent of the WTO.
Published here:
Updated here:
Pharmaceutics
The comment period closed on 16 January 2026. You can still raise concerns about the measure with your country's WTO TBT enquiry point, quoting the document symbol G/TBT/N/PHL/349/Add.1; it can take them up with the Philippines.
Find your country's enquiry point on WTO ePing (opens in a new tab)Latest notice (G/TBT/N/PHL/349/Add.1, 27 November 2025)
Classification of Pharmaceutical Products Intended for Human Use
The policy provides guidelines, and regulations in the classification and reclassification of pharmaceutical products (i.e., prescription pharmaceutical products, pharmacist-only non-prescription pharmaceutical products, general sales non-prescription pharmaceutical products, or household remedy).
Every notice about this measure published here, newest first. Each one is the notifying member's own text.
AddendumG/TBT/N/PHL/349/Add.1
Comment deadline: Closed on 16 January 2026
Classification of Pharmaceutical Products Intended for Human Use
Regular notificationG/TBT/N/PHL/349
Comment deadline: Closed on 21 November 2025
Classification of Pharmaceutical Products Intended for Human Use
The policy provides guidelines, and regulations in the classification and reclassification of pharmaceutical products (i.e., prescription pharmaceutical products, pharmacist-only non-prescription pharmaceutical products, general sales non-prescription pharmaceutical products, or household remedy).
Expodite writes its summary from the official record. The notification and the documents it notifies are on the WTO's own websites.
WTO notificationTBTProposed measure, open for commentsNew
The proposed FDA Circular aims to provide GMP guidelines for medical devices under PNS ISO 13485:2019. This Circular shall apply to all local manufacturers of medical devices, including IVD medical devices.
Symbol: G/TBT/N/PHL/379Comments until 2 January 2027
WTO notificationSPSProposed measure, open for commentsNew
This Circular is hereby issued to provide the updated guidelines and implementation procedures for the importation of dogs and cats into the Philippines. It outlines the documentary and animal health requirements, including the approved Sanitary and Phytosanitary Import Clearance (SPSIC), rabies…
Symbol: G/SPS/N/PHL/548Comments until 2 January 2027
WTO notificationTBTProposed measure, open for commentsNew
This Department Administrative Order (DAO) aims to establish the mandatory product certification requirements for specified Light Electric Vehicles (LEVs) and batteries for LEV applications intended for importation, manufacture, distribution, or sale in the Philippines, to ensure conformity with…
Symbol: G/TBT/N/PHL/378Comments until 13 December 2026
WTO notificationSPSProposed measure, open for commentsNew
This regulation provides clarifications on the hierarchy of food safety standards that have already been established and adopted as technical regulations, serving as points of reference for government agencies, international trading partners and local stakeholders. The scope of this regulation…
Symbol: G/SPS/N/PHL/547Comments until 19 December 2026
Expodite matches each notification to the markets you export to and the HS codes of your products, and puts the ones that concern you in your Updates centre, with the date comments close.